Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2
This study highlights the pivotal role of phagocytosis regulators, particularly HMGB2, in the progression of female-specific cancers. Targeting HMGB2 offers promising therapeutic opportunities, potentially enhancing precision oncology and improving patient outcomes.
Authors
- Zixuan Wang (ORCID: https://orcid.org/0000-0001-5345-2471)
- Dan Ren (ORCID: https://orcid.org/0000-0003-3738-6421)
- Panpan Zhao (ORCID: https://orcid.org/0000-0001-7217-7524)
- Xiaoqin Lu (ORCID: https://orcid.org/0000-0002-4136-6776)
- Yanfang Li (ORCID: https://orcid.org/0009-0009-0374-3583)
- Jingyan Zhang (ORCID: https://orcid.org/0009-0002-0662-2225)
Institutions
- Second Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.3389/fimmu.2025.1565924
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00